Security Snapshot

RADIOPHARM THERANOSTICS LIMITED - Ordinary Shares, as represented by American Depositary Shares Institutional Ownership

CUSIP: Q79455103

13F Institutional Holders and Ownership History

Latest Period

n/a

Institutions Reporting

Shares (Excl. Options)

Price

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.

Type / Class
Equity / Ordinary Shares, as represented by American Depositary Shares
Shares outstanding
3,641,998,775

Quick Takeaways

  • Q79455103 - RADIOPHARM THERANOSTICS LIMITED - Ordinary Shares, as represented by American Depositary Shares is tracked under CUSIP Q79455103.
  • Latest finished 13F holder period is not available.
  • 1 significant owner is listed from Schedule 13D/13G reporting.

What Changed

  • Quarterly ownership records are not available yet for this CUSIP.
  • This page updates as SEC-backed holdings history becomes available.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Schedule 13D/G

Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.

Open SEC Evidence

Investment Quick Answers

What is CUSIP Q79455103?
CUSIP Q79455103 identifies Q79455103 - RADIOPHARM THERANOSTICS LIMITED - Ordinary Shares, as represented by American Depositary Shares in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Significant Owners of RADIOPHARM THERANOSTICS LIMITED - Ordinary Shares, as represented by American Depositary Shares based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
JPMORGAN CHASE & CO 4% -56% 145,679,951 -34% JPMORGAN CHASE & CO. 31 Dec 2025
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .